However, all-trans retinoic acid (RA) can induce CD1d expression in glioblastoma stem-like cells, which promotes iNKT cells to exhibit higher cytotoxicity against α-GalCer (alpha-galactosylceramide)-pulsed patient glioblastoma stem-like cells [100]. The gene discussed is CD1D; the disease is glioblastoma.